- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07611422
Showers and Stress (S A S)
Effects of Repeated Cold Shower Exposure on Stress Response: A Psychophysiological Analysis With Expectancy Manipulation
Study Overview
Status
Conditions
Detailed Description
The study aims to explore the effect of repeated exposure to cold showers on the ability to respond positively to stressful stimuli. The psychophysiological effects of cold showers will be analyzed in combination with expectancy manipulation, which will be emphasized in only one of the two experimental conditions.
The study adopts a 2×2 factorial experimental design. The sample, consisting of approximately 120 healthy adults, will be randomly assigned to either an experimental group or a control group. Within each group, participants will be further subdivided based on the presence or absence of expectancy manipulation regarding the effectiveness of the intervention on stress management. In the experimental group, participants will be instructed to take warm or lukewarm showers at least four times per week at home, with the addition of a final 30-second exposure to cold water. The control group, on the other hand, will be asked to take only warm or lukewarm showers on a daily basis. The second factor considered is expectancy: one group will receive information designed to induce the expectation that this practice may improve stress management, while the other group will receive no specific information. At baseline assessment, participants will complete questionnaires aimed at evaluating psychological well-being, perceived stress, and quality of life. In addition, they will perform a Stroop task with restricted time limits, which is commonly used as a cognitive stressor, while wearing a heart rate monitoring device (Garmin Vivoactive 5). During the intervention phase, which will last four weeks, participants will keep a daily diary to track whether they performed the shower (cold/warm) and their levels of perceived stress. At the end of the intervention, the same measures administered at baseline will be collected again.
Methods and Instruments
The study involves the use of the following questionnaires:
- Demographic data (gender, age)
- Stress (Perceived Stress Scale, PSS-10)
- Resilience (Resilience Scale for Adults, RSA)
- Psychological well-being (Psychological General Well-Being Index, PGWBI-6) All questionnaires will be administered through the Qualtrics platform.
In addition, during the Stroop task, participants will wear a device (Garmin Vivoactive 5) to monitor physiological activation, assessed via heart rate. The psychophysiological data collection protocol includes a 5-minute resting baseline phase and a recording phase during the Stroop task. A visual analogue scale (VAS) measuring perceived stress will be administered both before and after the Stroop task. These assessments will be conducted both at baseline and at the end of the intervention period (i.e., 4 weeks after the initial assessment). During the intervention phase, participants will complete a daily paper diary, self-reported, including:
Time of the shower Approximate water temperature (hot, lukewarm, cold) For participants in the "cold shower" experimental group: compliance with the task (yes/no) Stress VAS ("today was a…" ranging from "very stressful" to "not stressful at all")
Research Procedure
Participants will be recruited through snowball sampling and word of mouth. The invitation will consist of a message such as: "take part in a study on the relationship between daily showering and well-being." After receiving detailed information about the study in person, those who agree to participate will sign an informed consent form. Participants will then be randomly assigned to one of four groups, in line with the 2×2 factorial design.
During the baseline data collection, participants will complete self-report questionnaires. They will then perform a Stroop task, used as a cognitive stressor, while heart rate will be recorded through a wearable device. Perceived stress will also be measured before and after the Stroop task in order to assess the task-induced stress response.
Depending on group allocation, participants will receive the following instructions:
Group 1 - Participants will be asked to end their shower, at least four times per week, at home (or in other locations of their choice), with at least 30 seconds of cold water exposure, preferably very cold. No specific rationale will be provided to support this request.
Group 2 - Participants will be asked to take warm showers at least four times per week, at home or in other locations of their choice. No specific rationale will be provided to support this request.
Group 3 - Participants will be asked to end their shower, at least four times per week, at home (or in other locations of their choice), with at least 30 seconds of cold water exposure, preferably very cold. This request will be supported by an explanation regarding the potential role of cold showers in promoting resilience and reducing stress.
Group 4 - Participants will be asked to take warm showers at least four times per week, at home or in other locations of their choice. This request will be supported by an explanation regarding the potential role of warm showers in promoting resilience and reducing stress.
The intervention phase will last four weeks, during which participants will keep a daily diary to monitor whether they completed the shower (cold/warm) and their levels of perceived stress.
At the end of the intervention, the same measures administered at baseline will be collected again. During the debriefing, the rationale and research design will be explained and, for Groups 3 and 4, informed consent will be requested again (to confirm or withdraw participation following disclosure of the deception).
Study Objectives
The main objective of the study is to investigate the effect of repeated exposure to cold showers on stress responses, assessed through both psychometric and physiological measures. In particular, the study aims to examine whether the inclusion of brief periods of cold water exposure within a daily routine can influence perceived stress levels, psychological well-being, and physiological responses to stress. A further objective is to explore the role of expectancy in the effectiveness of the intervention, by evaluating the extent to which the presence or absence of information about the beneficial effects of the assigned practice may modulate the observed psychological and physiological outcomes. To this end, the study will compare conditions with and without expectancy manipulation in both the experimental and the control groups.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Francesco Pagnini, Professor
- Phone Number: +39 3391942425
- Email: francesco.pagnini@unicatt.it
Study Contact Backup
- Name: Diletta Barbiani, Assistant professor
- Phone Number: +39 3338059338
- Email: diletta.barbiani@unicatt.it
Study Locations
-
-
-
Milan, Italy
- Recruiting
- Università Cattolica del Sacro Cuore
-
Contact:
- Francesco Pagnini, PhD
- Phone Number: +39 339 1942425
- Email: francesco.pagnini@unicatt.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
Participants will be eligible for the study if they meet the following criteria:
- Age ≥ 18 years
- Good general health status, self-reported and/or certified by a medical document (e.g., general medical certificate or sports medical clearance)
- Willingness to participate for the full duration of the study (4 weeks)
- Ability to understand and independently complete questionnaires and study diaries
- Signed informed consent
Exclusion Criteria
Participants will be excluded from the study if they present:
- Uncompensated cardiovascular, neurological, or endocrine conditions considered relevant to stress or cold exposure tolerance
- Medical conditions contraindicating cold exposure (e.g., Raynaud's phenomenon, cold urticaria, etc.)
- Pregnancy
- Use of medications that may interfere with stress responses (e.g., beta-blockers, anxiolytics, systemic corticosteroids)
- Acute or unstable psychiatric disorders
- Inability to comply with the experimental protocol or complete study materials
- Concurrent participation in other studies involving stress or physiological regulation interventions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cold shower + Neutral information
Participants will be asked to end their shower, at least four times per week, at home (or in other locations of their choice), with at least 30 seconds of cold water exposure, preferably very cold.
No specific rationale will be provided to support this request.
|
Partecipants will be exposed neutral information about the effects of warm and cold showers using a 2x2 factorial design
|
|
Experimental: Cold shower + Positive expectations
Participants will be asked to end their shower, at least four times per week, at home (or in other locations of their choice), with at least 30 seconds of cold water exposure, preferably very cold.
This request will be supported by an explanation regarding the potential role of cold showers in promoting resilience and reducing stress.
|
Partecipants will be exposed to positive information about the effects of warm and cold showers using a 2x2 factorial design
|
|
Active Comparator: Warm shower + Neutral information
Participants will be asked to take warm showers at least four times per week, at home or in other locations of their choice.
No specific rationale will be provided to support this request.
|
Partecipants will be exposed neutral information about the effects of warm and cold showers using a 2x2 factorial design
|
|
Experimental: Warm shower + Positive expectations
Participants will be asked to take warm showers at least four times per week, at home or in other locations of their choice.
This request will be supported by an explanation regarding the potential role of warm showers in promoting resilience and reducing stress.
|
Partecipants will be exposed to positive information about the effects of warm and cold showers using a 2x2 factorial design
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived stress
Time Frame: 4 weeks
|
Perceived stress will be assessed using the Perceived Stress Scale (PSS-10) to evaluate changes in perceived stress from baseline to the end of the study, including during exposure to the Stroop task.
Total scores range from 0 to 40, with higher scores indicating greater perceived stress and therefore a worse outcome.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate variability
Time Frame: 4 weeks
|
Change in heart rate while performing the the Stroop test at baseline and at follow-up.
|
4 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PlaSHOWER_MtBlab
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on No expectation regarding the exposure to cold water and/or to warm showers
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingNeurosurgical Procedures | Cadaveric Training | Minimally Invasive Techniques
-
Mondelēz International, Inc.BioFortisCompletedTolerance | Healthy PopulationUnited States
-
Indiana UniversityMedical University of South Carolina; National Institute of Diabetes and Digestive... and other collaboratorsRecruiting
-
NICHD Global Network for Women's and Children's...RecruitingPregnancy Outcome Trends in Low-resource Geographic AreasUnited States, Bangladesh, Democratic Republic of the Congo, Guatemala, India, Pakistan, Zambia
-
HIV Prevention Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Division of...CompletedHIV Infection | Sexually Transmitted Infections | Pre-exposure Prophylaxis | Systems NavigationMalawi
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States
-
Washington University School of MedicineInternational Headache SocietyActive, not recruitingMigraineUnited States
-
Stanford UniversityCompleted